Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
A brief guide to blue chip alternatives beyond BTC and ETH, highlighting characteristics that define blue chip status and potential rewards.
20,411 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Schwab U.S. Dividend Equity ETF SCHD remains a cornerstone for income investors as of mid-2026, combining a low fee w...
solana price prediction: buying momentum intensifies as on-chain data shows rising accumulation and renewed demand fo...
A two-day pension fund rebalance could move about $30 billion of U.S. stocks, posing near-term volatility but often a...
Antero Midstream logged 271% total returns over three years and closed a $1.1 billion Marcellus asset deal. The 2026 ...
Singapore's financial regulator placed Hyperliquid on its Investor Alert List, marking a consumer-protection test for...
Mortgage rates climbed above 6.25% to 6.41% as geopolitical tensions spiked, but housing demand still positive persis...
What if your paycheck could work harder for your future than you do today? This piece explains how pay yourself first...
Thousands are flocking North Carolina’s cities, drawn by opportunity, growing tech jobs, and affordable housing. This...
Strategy faces an $8 billion cash wall over the next two years as STRC trades well below par, sharpening questions ab...
A bold investing thesis centers on a single nuclear stock with big plans for small modular reactors and recycled fuel...
An accessible analysis of what this $405,000 bj's insider sale means for investors, plus practical steps to read insi...